Current status and future perspectives for the treatment of resectable locally advanced esophagogastric junction cancer: A narrative review
Incidence rates for esophagogastric junction cancer are rising rapidly worldwide possibly due to the economic development and demographic changes. Therefore, increased attention has been paid to the prevention, diagnosis, and the treatment of esophagogastric junction cancer. Although there are discr...
Gespeichert in:
| Veröffentlicht in: | World journal of gastroenterology : WJG 2023-06, Vol.29 (24), p.3758-3769 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3769 |
|---|---|
| container_issue | 24 |
| container_start_page | 3758 |
| container_title | World journal of gastroenterology : WJG |
| container_volume | 29 |
| creator | Shoji, Yoshiaki Koyanagi, Kazuo Kanamori, Kohei Tajima, Kohei Ogimi, Mika Yatabe, Kentaro Yamamoto, Miho Kazuno, Akihito Nabeshima, Kazuhito Nakamura, Kenji Nishi, Takayuki Mori, Masaki |
| description | Incidence rates for esophagogastric junction cancer are rising rapidly worldwide possibly due to the economic development and demographic changes. Therefore, increased attention has been paid to the prevention, diagnosis, and the treatment of esophagogastric junction cancer. Although there are discrepancies in the treatment strategy between Asian and Western countries, surgery remains the mainstay of treatment for esophagogastric junction cancer. Recent developments of perioperative multidisciplinary treatment may lead to better therapeutic effect, higher complete resection rate, and better control of the residual diseases, thus result in prolonged prognosis. In this review, we will focus on the treatment of locally advanced resectable esophagogastric junction cancer, and discuss the current status and future perspectives of the perioperative treatment including chemotherapy, radiation therapy, and immunotherapy, as well as the surgical strategy. Better understanding of the latest treatment strategy and future overlook may enable to standardize and individualize the treatment for esophagogastric junction cancer, thus leading to better prognosis for those patients. |
| doi_str_mv | 10.3748/wjg.v29.i24.3758 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10324534</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2839254355</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-8a38e68b3ee6fb1195284ca6469581d5e079dbb2c166005077d57f078d9c173c3</originalsourceid><addsrcrecordid>eNpVkc1u1DAURq0K1A5t96yQl2wy-CeOHTaoGgGtVIkNrK0b52Ymo0wcbCdVn4GXrqOWClaW_N3v2FeHkPecbaUuzaeH4367iHrbizJfKHNGNkLwuhCmZG_IhjOmi1oKfUHexXhkTEipxDm5yGVRSaE25M9uDgHHRGOCNEcKY0u7Oc0B6YQhTuhSv2CknQ80HZCmgJBOa8F3NGDMOTQD0sE7GIZHCu0Co8OWYvTTAfZ-DzGF3tHjPGaUH6lb8_CZ3tARQoAVn0FLjw9X5G0HQ8Trl_OS_Pr29efutrj_8f1ud3NfOFnrVBiQBivTSMSqazivVV7XQVVWtTK8Vch03TaNcLyqGFNM61bpjmnT1o5r6eQl-fLMnebmhK3L2wQY7BT6E4RH66G3_ydjf7B7v1jOpCiVLDPh4wsh-N8zxmRPfXQ4DDCin6MVRtZClVKpPMqeR13wMQbsXt_hzK4SbZZos0SbJdpVYq58-Pd_r4W_1uQTFd6d0A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2839254355</pqid></control><display><type>article</type><title>Current status and future perspectives for the treatment of resectable locally advanced esophagogastric junction cancer: A narrative review</title><source>PubMed (Medline)</source><source>Baishideng "World Journal of" online journals</source><source>Free E-Journal (出版社公開部分のみ）</source><source>Alma/SFX Local Collection</source><creator>Shoji, Yoshiaki ; Koyanagi, Kazuo ; Kanamori, Kohei ; Tajima, Kohei ; Ogimi, Mika ; Yatabe, Kentaro ; Yamamoto, Miho ; Kazuno, Akihito ; Nabeshima, Kazuhito ; Nakamura, Kenji ; Nishi, Takayuki ; Mori, Masaki</creator><creatorcontrib>Shoji, Yoshiaki ; Koyanagi, Kazuo ; Kanamori, Kohei ; Tajima, Kohei ; Ogimi, Mika ; Yatabe, Kentaro ; Yamamoto, Miho ; Kazuno, Akihito ; Nabeshima, Kazuhito ; Nakamura, Kenji ; Nishi, Takayuki ; Mori, Masaki</creatorcontrib><description>Incidence rates for esophagogastric junction cancer are rising rapidly worldwide possibly due to the economic development and demographic changes. Therefore, increased attention has been paid to the prevention, diagnosis, and the treatment of esophagogastric junction cancer. Although there are discrepancies in the treatment strategy between Asian and Western countries, surgery remains the mainstay of treatment for esophagogastric junction cancer. Recent developments of perioperative multidisciplinary treatment may lead to better therapeutic effect, higher complete resection rate, and better control of the residual diseases, thus result in prolonged prognosis. In this review, we will focus on the treatment of locally advanced resectable esophagogastric junction cancer, and discuss the current status and future perspectives of the perioperative treatment including chemotherapy, radiation therapy, and immunotherapy, as well as the surgical strategy. Better understanding of the latest treatment strategy and future overlook may enable to standardize and individualize the treatment for esophagogastric junction cancer, thus leading to better prognosis for those patients.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v29.i24.3758</identifier><identifier>PMID: 37426325</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Minireviews</subject><ispartof>World journal of gastroenterology : WJG, 2023-06, Vol.29 (24), p.3758-3769</ispartof><rights>The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.</rights><rights>The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. 2023</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-8a38e68b3ee6fb1195284ca6469581d5e079dbb2c166005077d57f078d9c173c3</citedby><cites>FETCH-LOGICAL-c397t-8a38e68b3ee6fb1195284ca6469581d5e079dbb2c166005077d57f078d9c173c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324534/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324534/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37426325$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shoji, Yoshiaki</creatorcontrib><creatorcontrib>Koyanagi, Kazuo</creatorcontrib><creatorcontrib>Kanamori, Kohei</creatorcontrib><creatorcontrib>Tajima, Kohei</creatorcontrib><creatorcontrib>Ogimi, Mika</creatorcontrib><creatorcontrib>Yatabe, Kentaro</creatorcontrib><creatorcontrib>Yamamoto, Miho</creatorcontrib><creatorcontrib>Kazuno, Akihito</creatorcontrib><creatorcontrib>Nabeshima, Kazuhito</creatorcontrib><creatorcontrib>Nakamura, Kenji</creatorcontrib><creatorcontrib>Nishi, Takayuki</creatorcontrib><creatorcontrib>Mori, Masaki</creatorcontrib><title>Current status and future perspectives for the treatment of resectable locally advanced esophagogastric junction cancer: A narrative review</title><title>World journal of gastroenterology : WJG</title><addtitle>World J Gastroenterol</addtitle><description>Incidence rates for esophagogastric junction cancer are rising rapidly worldwide possibly due to the economic development and demographic changes. Therefore, increased attention has been paid to the prevention, diagnosis, and the treatment of esophagogastric junction cancer. Although there are discrepancies in the treatment strategy between Asian and Western countries, surgery remains the mainstay of treatment for esophagogastric junction cancer. Recent developments of perioperative multidisciplinary treatment may lead to better therapeutic effect, higher complete resection rate, and better control of the residual diseases, thus result in prolonged prognosis. In this review, we will focus on the treatment of locally advanced resectable esophagogastric junction cancer, and discuss the current status and future perspectives of the perioperative treatment including chemotherapy, radiation therapy, and immunotherapy, as well as the surgical strategy. Better understanding of the latest treatment strategy and future overlook may enable to standardize and individualize the treatment for esophagogastric junction cancer, thus leading to better prognosis for those patients.</description><subject>Minireviews</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVkc1u1DAURq0K1A5t96yQl2wy-CeOHTaoGgGtVIkNrK0b52Ymo0wcbCdVn4GXrqOWClaW_N3v2FeHkPecbaUuzaeH4367iHrbizJfKHNGNkLwuhCmZG_IhjOmi1oKfUHexXhkTEipxDm5yGVRSaE25M9uDgHHRGOCNEcKY0u7Oc0B6YQhTuhSv2CknQ80HZCmgJBOa8F3NGDMOTQD0sE7GIZHCu0Co8OWYvTTAfZ-DzGF3tHjPGaUH6lb8_CZ3tARQoAVn0FLjw9X5G0HQ8Trl_OS_Pr29efutrj_8f1ud3NfOFnrVBiQBivTSMSqazivVV7XQVVWtTK8Vch03TaNcLyqGFNM61bpjmnT1o5r6eQl-fLMnebmhK3L2wQY7BT6E4RH66G3_ydjf7B7v1jOpCiVLDPh4wsh-N8zxmRPfXQ4DDCin6MVRtZClVKpPMqeR13wMQbsXt_hzK4SbZZos0SbJdpVYq58-Pd_r4W_1uQTFd6d0A</recordid><startdate>20230628</startdate><enddate>20230628</enddate><creator>Shoji, Yoshiaki</creator><creator>Koyanagi, Kazuo</creator><creator>Kanamori, Kohei</creator><creator>Tajima, Kohei</creator><creator>Ogimi, Mika</creator><creator>Yatabe, Kentaro</creator><creator>Yamamoto, Miho</creator><creator>Kazuno, Akihito</creator><creator>Nabeshima, Kazuhito</creator><creator>Nakamura, Kenji</creator><creator>Nishi, Takayuki</creator><creator>Mori, Masaki</creator><general>Baishideng Publishing Group Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230628</creationdate><title>Current status and future perspectives for the treatment of resectable locally advanced esophagogastric junction cancer: A narrative review</title><author>Shoji, Yoshiaki ; Koyanagi, Kazuo ; Kanamori, Kohei ; Tajima, Kohei ; Ogimi, Mika ; Yatabe, Kentaro ; Yamamoto, Miho ; Kazuno, Akihito ; Nabeshima, Kazuhito ; Nakamura, Kenji ; Nishi, Takayuki ; Mori, Masaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-8a38e68b3ee6fb1195284ca6469581d5e079dbb2c166005077d57f078d9c173c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Minireviews</topic><toplevel>online_resources</toplevel><creatorcontrib>Shoji, Yoshiaki</creatorcontrib><creatorcontrib>Koyanagi, Kazuo</creatorcontrib><creatorcontrib>Kanamori, Kohei</creatorcontrib><creatorcontrib>Tajima, Kohei</creatorcontrib><creatorcontrib>Ogimi, Mika</creatorcontrib><creatorcontrib>Yatabe, Kentaro</creatorcontrib><creatorcontrib>Yamamoto, Miho</creatorcontrib><creatorcontrib>Kazuno, Akihito</creatorcontrib><creatorcontrib>Nabeshima, Kazuhito</creatorcontrib><creatorcontrib>Nakamura, Kenji</creatorcontrib><creatorcontrib>Nishi, Takayuki</creatorcontrib><creatorcontrib>Mori, Masaki</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shoji, Yoshiaki</au><au>Koyanagi, Kazuo</au><au>Kanamori, Kohei</au><au>Tajima, Kohei</au><au>Ogimi, Mika</au><au>Yatabe, Kentaro</au><au>Yamamoto, Miho</au><au>Kazuno, Akihito</au><au>Nabeshima, Kazuhito</au><au>Nakamura, Kenji</au><au>Nishi, Takayuki</au><au>Mori, Masaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current status and future perspectives for the treatment of resectable locally advanced esophagogastric junction cancer: A narrative review</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World J Gastroenterol</addtitle><date>2023-06-28</date><risdate>2023</risdate><volume>29</volume><issue>24</issue><spage>3758</spage><epage>3769</epage><pages>3758-3769</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>Incidence rates for esophagogastric junction cancer are rising rapidly worldwide possibly due to the economic development and demographic changes. Therefore, increased attention has been paid to the prevention, diagnosis, and the treatment of esophagogastric junction cancer. Although there are discrepancies in the treatment strategy between Asian and Western countries, surgery remains the mainstay of treatment for esophagogastric junction cancer. Recent developments of perioperative multidisciplinary treatment may lead to better therapeutic effect, higher complete resection rate, and better control of the residual diseases, thus result in prolonged prognosis. In this review, we will focus on the treatment of locally advanced resectable esophagogastric junction cancer, and discuss the current status and future perspectives of the perioperative treatment including chemotherapy, radiation therapy, and immunotherapy, as well as the surgical strategy. Better understanding of the latest treatment strategy and future overlook may enable to standardize and individualize the treatment for esophagogastric junction cancer, thus leading to better prognosis for those patients.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>37426325</pmid><doi>10.3748/wjg.v29.i24.3758</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1007-9327 |
| ispartof | World journal of gastroenterology : WJG, 2023-06, Vol.29 (24), p.3758-3769 |
| issn | 1007-9327 2219-2840 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10324534 |
| source | PubMed (Medline); Baishideng "World Journal of" online journals; Free E-Journal (出版社公開部分のみ）; Alma/SFX Local Collection |
| subjects | Minireviews |
| title | Current status and future perspectives for the treatment of resectable locally advanced esophagogastric junction cancer: A narrative review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T04%3A48%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20status%20and%20future%20perspectives%20for%20the%20treatment%20of%20resectable%20locally%20advanced%20esophagogastric%20junction%20cancer:%20A%20narrative%20review&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Shoji,%20Yoshiaki&rft.date=2023-06-28&rft.volume=29&rft.issue=24&rft.spage=3758&rft.epage=3769&rft.pages=3758-3769&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v29.i24.3758&rft_dat=%3Cproquest_pubme%3E2839254355%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2839254355&rft_id=info:pmid/37426325&rfr_iscdi=true |